Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: Books Puddle, New York, NY, Estados Unidos de America
EUR 80,64
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New.
Publicado por LAP LAMBERT Academic Publishing Jul 2022, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
EUR 60,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Neuware -The aim of this study is to prepare matrix tablets of dexamethasone, that can manage the various factors-Patient compliances and conveniences, Manage time for administrating the drug, Reduce multiple doses ofdexamethasone, Desired therapeutic effect.The basic approach in development of matrix tablets is the use of co-processed diluents like micro crystalline cellulose (MCC), magnesium stearate, lactose etc and natural polymer like traganth gum provide slow disintegration of tablets after putting in oral cavity, thereby release the drug in stomach. The bioavailability of some drugs may be decreased due to absorption of drugs in saliva and also due to pregastric absorption of saliva containing dispersed drugs that pass down into the stomach.In this study I have chosen dexamethasone drug because it having half life of 4-6 hours and can be formulated as sustain type drug.Tablet formulation on the basis of optimized batch had 1.6% of dexamethasone with 98.4% excipients. In conclusion, it can be said that the studies were helpful in evolving sustain release or matrix tablets of dexamethasone.Books on Demand GmbH, Überseering 33, 22297 Hamburg 92 pp. Englisch.
Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: preigu, Osnabrück, Alemania
EUR 53,10
Cantidad disponible: 5 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. Formulation & Evaluation of Dexamethasone Matrix | Tablets for Poly Cystic Ovarian Syndrome (For the treatment of Polysyst) | Rampal Singh Kaurav (u. a.) | Taschenbuch | Englisch | 2022 | LAP LAMBERT Academic Publishing | EAN 9786204983424 | Verantwortliche Person für die EU: preigu GmbH & Co. KG, Lengericher Landstr. 19, 49078 Osnabrück, mail[at]preigu[dot]de | Anbieter: preigu.
Publicado por LAP LAMBERT Academic Publishing Jul 2022, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
EUR 60,90
Cantidad disponible: 2 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -The aim of this study is to prepare matrix tablets of dexamethasone, that can manage the various factors-Patient compliances and conveniences, Manage time for administrating the drug, Reduce multiple doses ofdexamethasone, Desired therapeutic effect.The basic approach in development of matrix tablets is the use of co-processed diluents like micro crystalline cellulose (MCC), magnesium stearate, lactose etc and natural polymer like traganth gum provide slow disintegration of tablets after putting in oral cavity, thereby release the drug in stomach. The bioavailability of some drugs may be decreased due to absorption of drugs in saliva and also due to pregastric absorption of saliva containing dispersed drugs that pass down into the stomach.In this study I have chosen dexamethasone drug because it having half life of 4-6 hours and can be formulated as sustain type drug.Tablet formulation on the basis of optimized batch had 1.6% of dexamethasone with 98.4% excipients. In conclusion, it can be said that the studies were helpful in evolving sustain release or matrix tablets of dexamethasone. 92 pp. Englisch.
Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: Majestic Books, Hounslow, Reino Unido
EUR 84,41
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. Print on Demand.
Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: Biblios, Frankfurt am main, HESSE, Alemania
EUR 85,48
Cantidad disponible: 4 disponibles
Añadir al carritoCondición: New. PRINT ON DEMAND.
Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: moluna, Greven, Alemania
EUR 47,68
Cantidad disponible: Más de 20 disponibles
Añadir al carritoCondición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Kaurav Rampal SinghThe authors of this book are Dr. Ravikant Gupta (Principal, Shri Rawatpura Sarkar Institute of Pharmacy, Chitrakoot, Dist. Satna) and Mr. Rampal Singh Kaurav (Head of Pharmaceutics Department).The aim of this s.
Publicado por LAP LAMBERT Academic Publishing, 2022
ISBN 10: 6204983423 ISBN 13: 9786204983424
Idioma: Inglés
Librería: AHA-BUCH GmbH, Einbeck, Alemania
EUR 61,63
Cantidad disponible: 1 disponibles
Añadir al carritoTaschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - The aim of this study is to prepare matrix tablets of dexamethasone, that can manage the various factors-Patient compliances and conveniences, Manage time for administrating the drug, Reduce multiple doses ofdexamethasone, Desired therapeutic effect.The basic approach in development of matrix tablets is the use of co-processed diluents like micro crystalline cellulose (MCC), magnesium stearate, lactose etc and natural polymer like traganth gum provide slow disintegration of tablets after putting in oral cavity, thereby release the drug in stomach. The bioavailability of some drugs may be decreased due to absorption of drugs in saliva and also due to pregastric absorption of saliva containing dispersed drugs that pass down into the stomach.In this study I have chosen dexamethasone drug because it having half life of 4-6 hours and can be formulated as sustain type drug.Tablet formulation on the basis of optimized batch had 1.6% of dexamethasone with 98.4% excipients. In conclusion, it can be said that the studies were helpful in evolving sustain release or matrix tablets of dexamethasone.